Late transcatheter removal of a Rashkind PDA occlusion device for persistent hemolysis using a modified transseptal sheath.
A patient developed hemolysis and hematuria 2 d after placement of a 12 mm Rashkind PDA occlusion device. Six days after placement, the device was snared from the ductus arteriosus and removed through a modified transseptal sheath. A 17 mm PDA occlusion device was successfully placed in the PDA, with resolution of the hematuria.
Grifka
R G
RG
Baylor College of Medicine, Houston, TX.
O'Laughlin
M P
MP
Mullins
C E
CE
D000743:Anemia, Hemolytic / Q000209:etiology / Q000628:therapy; D006328:Cardiac Catheterization / Q000295:instrumentation*; D002404:Catheterization / Q000295:instrumentation*; D002675:Child, Preschool; D017023:Coronary Angiography; D004374:Ductus Arteriosus, Patent / Q000000981:diagnostic imaging / Q000628:therapy*; D004868:Equipment Failure; D005260:Female; D006417:Hematuria / Q000628:therapy*; D006461:Hemolysis / Q000502:physiology*; D006801:Humans